Skip to main content
logo
Tanvex BioPharma, Inc. (TPE:6541)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.10
+1.05 (3.49%)
Oct 20, 2026, 1:30 PM CST

Tanvex BioPharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
8,24114,56510,6978,71512,37720,476
Market Cap Growth
-43.86%36.15%22.75%-29.59%-39.55%106.96%
Enterprise Value
9,73214,71811,6039,69113,13319,692
Last Close Price
31.1055.0064.6663.95101.30167.69

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
12.5336.32308.48141.91552.433787.62
PB Ratio
1.662.5611.9810.618.907.33
P/TBV Ratio
5.286.3412.0710.668.977.35

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
14.8036.71334.59157.80586.213642.61

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.420.281.852.111.320.63
Net Debt / Equity Ratio
0.300.121.421.650.76-0.17
Net Debt / EBITDA Ratio
-1.15-0.56-1.01-0.68-0.710.31
Net Debt / FCF Ratio
-0.85-0.42-1.01-0.90-0.740.33
Asset Turnover
0.090.080.010.020.010.00
Inventory Turnover
4.892.640.160.010.320.03
Quick Ratio
0.991.301.171.152.689.06
Current Ratio
1.471.871.941.663.449.66
Return on Equity (ROE)
-29.78%-45.55%-161.17%-193.18%-78.41%-56.99%
Return on Assets (ROA)
-12.28%-16.22%-30.84%-42.47%-24.68%-22.00%
Return on Capital Employed (ROCE)
-21.00%-19.40%-56.80%-87.50%-51.50%-35.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-17.78%-10.30%-12.91%-24.52%-13.26%-7.54%
FCF Yield
-21.19%-11.49%-11.75%-17.29%-11.53%-6.92%
Buyback Yield / Dilution
-32.96%-57.76%-20.44%-9.60%-8.31%-21.32%